Peroxisome proliferator-activated receptor γ activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure

Molecular and Cellular Biology

Volumn 29, Issue 8, 2009, Pages 2053-2067

  Evans Molina, Carmella ^a,b   Robbins, Reiesha D ^b   Kono, Tatsuyoshi ^a   Tersey, Sarah A ^a   Vestermark, George L ^a   Nunemaker, Craig S ^b   Garmey, James C ^b   Deering, Tye G ^b   Keller, Susanna R ^b   Maier, Bernhard ^a   Mirmira, Raghavendra G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; THAPSIGARGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; EUCHROMATIN; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; ENDOPLASMIC RETICULUM; EUCHROMATIN; GLUCOSE TRANSPORTER TYPE 2; HOMEODOMAIN PROTEINS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; PPAR GAMMA; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANS-ACTIVATORS; UP-REGULATION;

ANIMALIA; MUS;

EID: 64649092274     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01179-08     Document Type: Article

References (62)

1. Amrani, A., S. Durant, M. Throsby, J. Coulaud, M. Dardenne, and F. Homo-Delarche. 1998. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 139:1115-1124.
2. Brunham, L. R., J. K. Kruit, T. D. Pape, J. M. Timmins, A. Q. Reuwer, Z. Vasanji, B. J. Marsh, B. Rodrigues, J. D. Johnson, J. S. Parks, C. B. Verchere, and M. R. Hayden. 2007. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat. Med. 13:340-347.
3. Campbell, I. W., and S. Mariz. 2007. Beta-cell preservation with thiazol-idinediones. Diabetes Res. Clin. Pract. 76:163-176.
4. Chakrabarti, S. K., J. Francis, S. M. Ziesmann, J. C. Garmey, and R. G. Mirmira. 2003. Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J. Biol. Chem. 278:23617-23623.
5. Chakrabarti, S. K., J. C. James, and R. G. Mirmira. 2002. Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277:13286-13293.
6. Deering, T. G., T. Ogihara, A. P. Trace, B. Maier, and R. G. Mirmira. 2009. Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 58:185-193.
7. Diani, A. R., G. Sawada, B. Wyse, F. T. Murray, and M. Khan. 2004. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 286:E116-E122.
8. Dubois, M., F. Pattou, J. Kerr-Conte, V. Gmyr, B. Vandewalle, P. Des-reumaux, J. Auwerx, K. Schoonjans, and J. Lefebvre. 2000. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells. Diabetologia 43:1165-1169.
9. Eizirik, D. L., A. K. Cardozo, and M. Cnop. 2008. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29:42-61.
10. Finegood, D. T., M. D. McArthur, D. Kojwang, M. J. Thomas, B. G. Topp, T. Leonard, and R. E. Buckingham. 2001. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50:1021-1029.
11. Francis, J., S. K. Chakrabarti, J. C. Garmey, and R. G. Mirmira. 2005. Pdx1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription. J. Biol. Chem. 280:36244- 36253.
12. Gastaldelli, A., E. Ferrannini, Y. Miyazaki, M. Matsuda, A. Mari, and R. A. DeFronzo. 2007. Thiazolidinediones improve beta-cell function in type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab. 292:E871-E883.
13. Gerstein, H. C., S. Yusuf, J. Bosch, J. Pogue, P. Sheridan, N. Dinccag, M. Hanefeld, B. Hoogwerf, M. Laakso, V. Mohan, J. Shaw, B. Zinman, and R. R. Holman. 2006. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096-1105.
14. Gilon, P., and J. C. Henquin. 1995. Distinct effects of glucose on the synchronous oscillations of insulin release and cytoplasmic Ca2+ concentration measured simultaneously in single mouse islets. Endocrinology 136:5725-5730.
15. Guest, P. C., C. J. Rhodes, and J. C. Hutton. 1989. Regulation of the biosynthesis of insulin-secretory-granule proteins. Co-ordinate translational control is exerted on some, but not all, granule matrix constituents. Biochem. J. 257:431-437.
16. Gupta, D., T. L. Jetton, R. M. Mortensen, S. Z. Duan, M. Peshavaria, and J. L. Leahy. 2008. In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter. J. Biol. Chem. 283:32462-32470.
17. Henquin, J. C., M. Nenquin, P. Stiernet, and B. Ahren. 2006. In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. Diabetes 55:441-451.
18. Higa, M., Y. T. Zhou, M. Ravazzola, D. Baetens, L. Orci, and R. H. Unger. 1999. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc. Natl. Acad. Sci. USA 96:11513-11518.
19. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424-430.
20. Holland, A. M, M. A. Hale, H. Kagami, R. E. Hammer, and R. J. Mac-Donald. 2002. Experimental control of pancreatic development and maintenance. Proc. Natl. Acad. Sci. USA 99:12236-12241.
21. Im, S. S., J. W. Kim, T. H. Kim, X. L. Song, S. Y. Kim, H. I. Kim, and Y. H. Ahn. 2005. Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter. Exp. Mol. Med. 37:101-110.
22. Ishida, H., M. Takizawa, S. Ozawa, Y. Nakamichi, S. Yamaguchi, H. Kat-suta, T. Tanaka, M. Maruyama, H. Katahira, K. Yoshimoto, E. Itagaki, and S. Nagamatsu. 2004. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: possible protection of beta cells from oxidative stress. Metabolism 53:488-494.
23. Iype, T., J. Francis, J. C. Garmey, J. C. Schisler, R. Nesher, G. C. Weir, T. C. Becker, C. B. Newgard, S. C. Griffen, and R. G. Mirmira. 2005. Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. J. Biol. Chem. 280: 16798-16807.
24. Jahanshahi, P., R. Wu, J. D. Carter, and C. S. Nunemaker. 2009. Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets. Endocrinology 150:607-615.
25. Kawasaki, F., M. Matsuda, Y. Kanda, H. Inoue, and K. Kaku. 2005. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am. J. Physiol. Endocrinol. Metab. 288:E510-E518.
26. Kim, H. I., and Y. H. Ahn. 2004. Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells. Diabetes 53(Suppl. l):S60-S65.
27. Kim, H. I., J. W. Kim, S. H. Kim, J. Y. Cha, K. S. Kim, and Y. H. Ahn. 2000. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 49:1517-1524.
28. Kulkarni, R. N, M. G. Roper, G. Dahlgren, D. Q. Shih, L. M. Kauri, J. L. Peters, M. Stoffel, and R. T. Kennedy. 2004. Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3. Diabetes 53:1517-1525.
29. Lazar, M. A. 2005. PPAR gamma, 10 years later. Biochimie 87:9-13.
30. Lincoff, A, M, K. Wolski, S. J. Nicholls, and S. E. Nissen. 2007. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298:1180-1188.
31. Lipson, K. L., S. G. Fonseca, S. Ishigaki, L. X. Nguyen, E. Foss, R. Bortell, A. A. Rossini, and F. Urano. 2006. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 4:245-254.
32. Meier, J. J., A. E. Butler, R. Galasso, and P. C. Butler. 2006. Hyperinsu-linemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29:1554-1559.
33. Moibi, J. A., D. Gupta, T. L. Jetton, M. Peshavaria, R. Desai, and J. L. Leahy. 2007. Peroxisome proliferator-activated receptor-γ regulates expression of PDX-1 and NKX6.1 in INS-1 cells. Diabetes 56:88-95.
34. Morioka, T., E. Asilmaz, J. Hu, J. F. Dishinger, A. J. Kurpad, C. F. Elias, H. Li, J. K. Elmquist, R. T. Kennedy, and R. N. Kulkarni. 2007. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J. Clin. Investig. 117:2860-2868.
35. Mosley, A. L., and S. Ozcan. 2003. Glucose regulates insulin gene transcription by hyperacetylation of histone H4. J. Biol. Chem. 278:19660-19666.
36. Mutskov, V., B. M. Raaka, G. Felsenfeld, and M. C. Gershengorn. 2007. The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression. Stem Cells 25:3223-3233.
37. Nishioka, K., S. Chuikov, K. Sarma, H. Erdjument-Bromage, C. D. Allis, P. Tempst, and D. Reinberg. 2002. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 16:479-489.
38. Nissen, S. E., S. J. Nicholls, K. Wolski, R. Nesto, S. Kupfer, A, Perez, H. Jure, R. De Larochelliere, C. S. Staniloae, K. Mavromatis, J. Saw, B. Hu, A. M. Lincoff, and E. M. Tuzcu. 2008. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 299:1561-1573.
39. Nissen, S. E., and K. Wolski. 2007. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356:2457-2471.
40. i oscillations in pancreatic islets via ionic and glycolytic mechanisms. Biophys. J. 91:2082-2096.
41. Nunemaker, C. S., M. Zhang, D. H. Wasserman, O. P. McGuinness, A. C. Powers, R. Bertram, A. Sherman, and L. S. Satin. 2005. Individual mice can be distinguished by the period of their islet calcium oscillations: is there an intrinsic islet period that is imprinted in vivo? Diabetes 54:3517-3522.
42. Okada, T., C. W. Liew, J. Hu, C. Hinault, M. D. Michael, J. Krtzfeldt, C. Yin, M. Holzenberger, M. Stoffel, and R. N. Kulkarni. 2007. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc. Natl. Acad. Sci. USA 104:8977-8982.
43. O'Rahilly, S., R. C. Turner, and D. R. Matthews. 1988. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N. Engl. J. Med. 318:1225-1230.
44. Porksen, N., M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz. 2002. Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51(Suppl. 1):S245-S254.
45. Pray-Grant, M. G., J. A. Daniel, D. Schieltz, J. R. Yates 3rd, and P. A. Grant. 2005. Chdl chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 433:434-438.
46. Prentki, M., and C. J. Nolan. 2006. Islet beta cell failure in type 2 diabetes. J. Clin. Investig. 116:1802-1812.
47. Roe, M. W., L. H. Philipson, C. J. Frangakis, A. Kuznetsov, R. J. Mertz, M. E. Lancaster, B. Spencer, J. F. Worley 3rd, and I. D. Dukes. 1994. Defective glucose-dependent endoplasmic reticulum Ca2+ sequestration in diabetic mouse islets of Langerhans. J. Biol. Chem. 269:18279-18282.
48. Rosen, E. D., R. N. Kulkarni, P. Sarraf, U. Ozcan, T. Okada, C. H. Hsu, D. Eisenman, M. A. Magnuson, F. J. Gonzalez, C. R. Kahn, and B. M. Spiegelman. 2003. Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol. Cell. Biol. 23:7222-7229.
49. Sears, D. D., A. Hsiao, J. M. Ofrecio, J. Chapman, W. He, and J. M. Olefsky. 2007. Selective modulation of promoter recruitment and transcriptional activity of PPARγ. Biochem. Biophys. Res. Commun. 364:515-521.
50. Singh, S., Y. K. Loke, and C. D. Furberg. 2007. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 298:1189-1195.
51. Song, B., D. Scheuner, D. Ron, S. Pennathur, and R. J. Kaufman. 2008. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Investig. 118:3378-3389.
52. U.K. Prospective Diabetes Study Group. 1995. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258.
53. Waeber, G., N. Thompson, P. Nicod, and C. Bonny. 1996. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10:1327-1334.
54. Wang, H., R. Cao, L. Xia, H. Erdjument-Bromage, C. Borchers, P. Tempst, and Y. Zhang. 2001. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol. Cell 8:1207-1217.
55. Watada, H., Y. Kajimoto, Y. Umayahara, T. Matsuoka, H. Kaneto, Y. Fuji-tani, T. Kamada, R. Kawamori, and Y. Yamasaki. 1996. The human glu-cokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 45:1478-1488.
56. Wilcox, R., S. Kupfer, and E. Erdmann. 2008. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10). Am. Heart J. 155:712-717.
57. Xiang, A, H., R. K. Peters, S. L. Kjos, A, Marroquin, J. Goico, C. Ochoa, M. Kawakubo, and T. A. Buchanan. 2006. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55:517-522.
58. Yajima, K., H. Hirose, H. Fujita, Y. Seto, H. Fujita, K. Ukeda, K. Miyashita, T. Kawai, Y. Yamamoto, T. Ogawa, T. Yamada, and T. Saruta. 2003. Combination therapy with PPARγ and PPARα agonists increases glucose-stimulated insulin secretion in db/db mice. Am. J. Physiol. Endocrinol. Metab. 284:E966-E971.
59. Yang, Z., M. Chen, J. D. Ellett, L. B. Fialkow, J. D. Carter, and J. L. Nadler. 2004. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation. Transplantation 77:55-60.
60. Yki-Järvinen, H. 2004. Thiazolidinediones. N. Engl. J. Med. 351:1106-1118.
61. Zarain-Herzberg, A., and G. Alvarez-Fernandez. 2002. Sarco(endo)plasmic reticulum Ca2+-ATPase-2 gene: structure and transcriptional regulation of the human gene. ScientificWorldJournal 2:1469-1483.
62. Zhang, M., P. Goforth, R. Bertram, A. Sherman, and L. Satin. 2003. The Ca2+ dynamics of isolated mouse beta-cells and islets: implications for mathematical models. Biophys. J. 84:2852-2870.